Corvus Pharmaceuticals Inc buy Jefferies Financial Group Inc.
Start price
22.01.26
/
50%
€21.55
Target price
22.01.27
-
Performance (%)
-27.05%
Price
06.02.26
€15.74
Summary
This prediction is currently active. The price of Corvus Pharmaceuticals Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -27.05%. This prediction currently runs until 22.01.27. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Corvus Pharmaceuticals Inc | - |
| iShares Core DAX® | 0.463% |
| iShares Nasdaq 100 | -1.792% |
| iShares Nikkei 225® | 5.124% |
| iShares S&P 500 | -1.760% |
Comments by Jefferies_Financial_ for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals (NASDAQ:CRVS) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for CRVS provided by MarketBeat